Comparison and Assessment of Pathobiologic Indices to Predict Oncotype DX Recurrence Scores

被引：0
|
作者：
Soong, Thing Rinda [1 ]
Geradts, Joseph [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
270
引用
收藏
页码：265 / 266
页数：2
相关论文
共 50 条
  • [41] Differential Distribution of Actual and Surrogate Oncotype DX Recurrence Scores by Age, Race, and Body Mass Index
    Mohamed, Anas
    Kousar, Aisha
    Geradts, Joseph
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 164 - 165
  • [42] Differential Distribution of Actual and Surrogate Oncotype DX Recurrence Scores by Age, Race, and Body Mass Index
    Mohamed, Anas
    Kousar, Aisha
    Geradts, Joseph
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 164 - 165
  • [43] The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort
    Ademuyiwa, Foluso O.
    Miller, Austin
    O'Connor, Tracey
    Edge, Stephen B.
    Thorat, Mangesh A.
    Sledge, George W.
    Levine, Ellis
    Badve, Sunil
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (03) : 797 - 802
  • [44] Patterns of Oncotype DX Recurrence Scores Analysis Based on Levels of ER & PR Expression and Proliferation Markers
    Burge, M.
    Frame, S.
    McGrath, P.
    Romond, E.
    Fjallskog, M-L
    Ahlin, C.
    Cibull, M.
    Brill, Y.
    Samayoa, L. M.
    LABORATORY INVESTIGATION, 2012, 92 : 27A - 27A
  • [45] Association Between Phosphorylated Histone H3 and Oncotype DX Recurrence Scores in Breast Cancer
    Lee, Lik Hang
    Swanson, Paul E.
    Tang, Patricia A.
    Bigras, Gilbert
    Yang, Hua
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (01) : 25 - 31
  • [46] Predicting Oncotype DX recurrence scores using clinicopathologic features: Tennessee University Nomogram: An external validation
    Pikabea Diaz, F.
    Galve Calvo, E.
    Zumarraga, A.
    Figaredo Bejarano, C.
    Sala Gonzalez, M. A.
    Lopez Santillan, M.
    De San Vicente, B. Lopez
    Casado, P.
    Martinez del Prado, M. P.
    ANNALS OF ONCOLOGY, 2022, 33 : S233 - S233
  • [47] Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
    Richard Buus
    Zsolt Szijgyarto
    Eugene F. Schuster
    Hui Xiao
    Ben P. Haynes
    Ivana Sestak
    Jack Cuzick
    Laia Paré
    Elia Seguí
    Nuria Chic
    Aleix Prat
    Mitch Dowsett
    Maggie Chon U. Cheang
    npj Breast Cancer, 7
  • [48] Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®
    Buus, Richard
    Szijgyarto, Zsolt
    Schuster, Eugene F.
    Xiao, Hui
    Haynes, Ben P.
    Sestak, Ivana
    Cuzick, Jack
    Pare, Laia
    Segui, Elia
    Chic, Nuria
    Prat, Aleix
    Dowsett, Mitch
    Cheang, Maggie Chon U.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [49] Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy
    Buus, Richard
    Sestak, Ivana
    Kronenwett, Ralf
    Denkert, Carsten
    Dubsky, Peter
    Krappmann, Kristin
    Scheer, Marsel
    Petry, Christoph
    Cuzick, Jack
    Dowsett, Mitch
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (11):
  • [50] Can Conventional Histopathologic Prognostic Parameters of Invasive Breast Carcinoma Predict the Oncotype DX™ Recurrence Score
    Bose, S.
    Mannan, A. A. S. R.
    Rathgeb, T.
    LABORATORY INVESTIGATION, 2011, 91 : 29A - 29A
12345